Bats and Coronaviruses

by Arinjay Banerjee, Kirsten Kulcsar, Vikram Misra, Matthew Frieman, Karen Mossman
Published 2019-01-01

Yeast based small molecule screen for inhibitors of SARS-CoV.

by Matthew Frieman, Dipanwita Basu, Krystal Matthews, Justin Taylor, Grant Jones, Raymond Pickles, Ralph Baric, Daniel A Engel
Published 2011-01-01

SARS-CoV-2 vaccines for all but a single dose for COVID-19 survivors

by Matthew Frieman, Anthony D. Harris, Ramin Sedaghat Herati, Florian Krammer, Alberto Mantovani, Maria Rescigno, Mohammad M. Sajadi, Viviana Simon
Published 2021-06-01

NKT Cell Responses to B Cell Lymphoma

by Junxin Li, Wenji Sun, Priyanka B. Subrahmanyam, Carly Page, Kenisha M. Younger, Irina V. Tiper, Matthew Frieman, Amy S. Kimball, Tonya J. Webb
Published 2014-04-01

MERS-CoV pathogenesis and antiviral efficacy of licensed drugs in human monocyte-derived antigen-presenting cells.

by Yu Cong, Brit J Hart, Robin Gross, Huanying Zhou, Matthew Frieman, Laura Bollinger, Jiro Wada, Lisa E Hensley, Peter B Jahrling, Julie Dyall, Michael R Holbrook
Published 2018-01-01

Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine: In Vitro Activity against SARS-CoV‑2 and Potential Mechanisms

by Ana C. Puhl, Ethan J. Fritch, Thomas R. Lane, Longping V. Tse, Boyd L. Yount, Carolina Q. Sacramento, Natalia Fintelman-Rodrigues, Tatyana Almeida Tavella, Fabio Trindade Maranhão Costa, Stuart Weston, James Logue, Matthew Frieman, Lakshmanane Premkumar, Kenneth H. Pearce, Brett L. Hurst, Carolina Horta Andrade, James A. Levi, Nicole J. Johnson, Samantha C. Kisthardt, Frank Scholle, Thiago Moreno L. Souza, Nathaniel John Moorman, Ralph S. Baric, Peter B. Madrid, Sean Ekins
Published 2021-03-01